ZA984268B - Method and composition for administering taxanes orally to human patients - Google Patents
Method and composition for administering taxanes orally to human patientsInfo
- Publication number
- ZA984268B ZA984268B ZA984268A ZA984268A ZA984268B ZA 984268 B ZA984268 B ZA 984268B ZA 984268 A ZA984268 A ZA 984268A ZA 984268 A ZA984268 A ZA 984268A ZA 984268 B ZA984268 B ZA 984268B
- Authority
- ZA
- South Africa
- Prior art keywords
- composition
- human patients
- administering taxanes
- taxanes orally
- orally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86351397A | 1997-05-27 | 1997-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA984268B true ZA984268B (en) | 1999-06-23 |
Family
ID=25341241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA984268A ZA984268B (en) | 1997-05-27 | 1998-05-20 | Method and composition for administering taxanes orally to human patients |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0994706B1 (ko) |
JP (1) | JP2002500667A (ko) |
KR (1) | KR100615783B1 (ko) |
CN (2) | CN1550231A (ko) |
AR (1) | AR012731A1 (ko) |
AT (1) | ATE308365T1 (ko) |
AU (1) | AU7130098A (ko) |
BR (1) | BR9809694A (ko) |
CA (1) | CA2290446C (ko) |
CZ (1) | CZ9904244A3 (ko) |
DE (1) | DE69832173T2 (ko) |
DK (1) | DK0994706T3 (ko) |
ES (1) | ES2247690T3 (ko) |
HK (1) | HK1026637A1 (ko) |
HU (1) | HUP0003546A3 (ko) |
IL (2) | IL132992A0 (ko) |
NO (1) | NO995812L (ko) |
PL (1) | PL337064A1 (ko) |
RU (1) | RU2205005C2 (ko) |
SK (1) | SK157599A3 (ko) |
UA (1) | UA74767C2 (ko) |
WO (1) | WO1998053811A1 (ko) |
ZA (1) | ZA984268B (ko) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6964946B1 (en) * | 1995-10-26 | 2005-11-15 | Baker Norton Pharmaceuticals, Inc. | Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
CA2294606A1 (en) * | 1997-06-20 | 1998-12-30 | Baker Norton Pharmaceuticals, Inc. | Soluble prodrugs of paclitaxel |
GB9718903D0 (en) | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
DE60030283T2 (de) | 1999-05-17 | 2007-09-20 | Cancer Research Ventures Ltd. | Zusammensetzungen zur erhöhung der bioverfügbarkeit von oral verabreichten pharmazeutischen verbindungen |
SK5822002A3 (en) * | 1999-10-27 | 2003-01-09 | Baker Norton Pharma | Method and compositions for administering taxanes orally to human patients |
KR20020013174A (ko) * | 2000-08-11 | 2002-02-20 | 민경윤 | 경구 흡수율이 낮은 약물의 흡수율을 증가시키기 위한경구용 조성물 |
MXPA03006404A (es) * | 2001-01-18 | 2004-12-02 | Upjohn Co | Composiciones quimioterapeuticas de microemulsion de paclitaxel con biodisponibilidad oral mejorada. |
US7115565B2 (en) | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
UY27185A1 (es) * | 2001-02-28 | 2002-09-30 | Bristol Myers Squibb Co | Dosificación metronómica de taxanos |
SI1372636T1 (sl) * | 2001-02-28 | 2006-12-31 | Bristol Myers Squibb Co | Metronomsko odmerjanje taksanov za inhibiranje tumorske rasti |
US7063977B2 (en) | 2001-08-21 | 2006-06-20 | Bristol-Myers Squibb Company | Enzymatic resolution of t-butyl taxane derivatives |
GB0523659D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
EP2438047B1 (en) * | 2009-06-02 | 2014-07-30 | Nikan Pharmaceuticals, LLC | Antagonism of human formyl peptide receptor for treatment of disease |
BR112023018826A2 (pt) * | 2021-03-17 | 2024-03-12 | Dompe Farm Spa | Inibidores de c5ar1 para tratamento de reações de hipersensibilidade a taxanos |
EP4059497A1 (en) * | 2021-03-17 | 2022-09-21 | Dompé farmaceutici S.p.a. | C5ar1 inhibitors for treating hypersensitivity reactions to taxanes |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5411947A (en) * | 1989-06-28 | 1995-05-02 | Vestar, Inc. | Method of converting a drug to an orally available form by covalently bonding a lipid to the drug |
ATE139447T1 (de) * | 1990-12-18 | 1996-07-15 | Wellcome Found | Mittel zur verstaerkung der wirkung von antitumoralen mittel und zur widerstandsbekaempfung von vielfachdrogen |
EP0569380B1 (en) * | 1991-01-11 | 1997-05-28 | Laboratoires Glaxo Sa | Acridine derivatives |
US5567592A (en) * | 1994-02-02 | 1996-10-22 | Regents Of The University Of California | Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal |
ATE176464T1 (de) * | 1994-07-26 | 1999-02-15 | Indena Spa | Semisynthetisch taxal derivate mit antitumor wirkung |
TW354293B (en) * | 1995-06-06 | 1999-03-11 | Bristol Myers Squibb Co | Prodrugs of paclitaxel derivatives |
EP0831870A4 (en) * | 1995-06-07 | 1998-09-16 | Avmax Inc | USE OF ESSENTIAL OILS TO INCREASE THE BIOAVAILABILITY OF ORAL PHARMACEUTICAL COMPOUNDS |
US6245805B1 (en) * | 1995-10-26 | 2001-06-12 | Baker Norton Pharmaceuticals, Inc. | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
WO1997027855A1 (en) * | 1996-01-31 | 1997-08-07 | Bristol-Myers Squibb Company | A method of making pharmaceutically active taxanes orally bioavailable |
AU3486297A (en) * | 1996-06-17 | 1998-01-07 | Eli Lilly And Company | Drug resistance and multidrug resistance modulators |
GB9718903D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
DE69931617T2 (de) * | 1998-04-01 | 2007-05-24 | Jagotec Ag | Taxan-mikroemulsionen |
-
1998
- 1998-04-22 KR KR1019997011000A patent/KR100615783B1/ko not_active IP Right Cessation
- 1998-04-22 CN CNA2004100304785A patent/CN1550231A/zh active Pending
- 1998-04-22 ES ES98918361T patent/ES2247690T3/es not_active Expired - Lifetime
- 1998-04-22 CN CN98806440A patent/CN1261275A/zh active Pending
- 1998-04-22 AT AT98918361T patent/ATE308365T1/de not_active IP Right Cessation
- 1998-04-22 AU AU71300/98A patent/AU7130098A/en not_active Abandoned
- 1998-04-22 BR BR9809694-0A patent/BR9809694A/pt not_active IP Right Cessation
- 1998-04-22 SK SK1575-99A patent/SK157599A3/sk unknown
- 1998-04-22 JP JP50066399A patent/JP2002500667A/ja active Pending
- 1998-04-22 HU HU0003546A patent/HUP0003546A3/hu unknown
- 1998-04-22 CA CA002290446A patent/CA2290446C/en not_active Expired - Fee Related
- 1998-04-22 DK DK98918361T patent/DK0994706T3/da active
- 1998-04-22 PL PL98337064A patent/PL337064A1/xx unknown
- 1998-04-22 RU RU99128033/14A patent/RU2205005C2/ru not_active IP Right Cessation
- 1998-04-22 EP EP98918361A patent/EP0994706B1/en not_active Expired - Lifetime
- 1998-04-22 DE DE69832173T patent/DE69832173T2/de not_active Expired - Fee Related
- 1998-04-22 IL IL13299298A patent/IL132992A0/xx active IP Right Grant
- 1998-04-22 WO PCT/US1998/007776 patent/WO1998053811A1/en active IP Right Grant
- 1998-04-22 UA UA99116450A patent/UA74767C2/uk unknown
- 1998-04-22 CZ CZ19994244A patent/CZ9904244A3/cs unknown
- 1998-05-20 ZA ZA984268A patent/ZA984268B/xx unknown
- 1998-05-21 AR ARP980102356A patent/AR012731A1/es unknown
-
1999
- 1999-11-17 IL IL132992A patent/IL132992A/en not_active IP Right Cessation
- 1999-11-26 NO NO995812A patent/NO995812L/no not_active Application Discontinuation
-
2000
- 2000-09-20 HK HK00105943A patent/HK1026637A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69832173T2 (de) | 2006-08-03 |
CZ9904244A3 (cs) | 2001-10-17 |
ATE308365T1 (de) | 2005-11-15 |
HK1026637A1 (en) | 2000-12-22 |
EP0994706A4 (en) | 2001-05-16 |
WO1998053811A1 (en) | 1998-12-03 |
EP0994706A1 (en) | 2000-04-26 |
ES2247690T3 (es) | 2006-03-01 |
EP0994706B1 (en) | 2005-11-02 |
CN1550231A (zh) | 2004-12-01 |
NO995812L (no) | 2000-01-25 |
SK157599A3 (en) | 2002-10-08 |
IL132992A (en) | 2006-08-20 |
CA2290446C (en) | 2008-01-29 |
KR20010013025A (ko) | 2001-02-26 |
AR012731A1 (es) | 2000-11-08 |
CA2290446A1 (en) | 1998-12-03 |
UA74767C2 (en) | 2006-02-15 |
BR9809694A (pt) | 2000-10-03 |
HUP0003546A2 (hu) | 2002-11-28 |
NO995812D0 (no) | 1999-11-26 |
AU7130098A (en) | 1998-12-30 |
JP2002500667A (ja) | 2002-01-08 |
CN1261275A (zh) | 2000-07-26 |
HUP0003546A3 (en) | 2002-12-28 |
DK0994706T3 (da) | 2006-03-06 |
PL337064A1 (en) | 2000-07-31 |
KR100615783B1 (ko) | 2006-08-25 |
IL132992A0 (en) | 2001-03-19 |
RU2205005C2 (ru) | 2003-05-27 |
DE69832173D1 (de) | 2005-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL341592A1 (en) | Method of administering human aspb28 insulin | |
HUP0103357A3 (en) | Halichondrin analogs and methods of their use and preparation | |
CY2007001I1 (el) | Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη | |
HK1022835A1 (en) | Pharmaceutical composition for treatment of diabetes | |
AU1805499A (en) | Method and apparatus for delivery of therapeutic agents to the heart | |
HK1151462A1 (zh) | 用於將物質給藥的植入物以及製備植入物的方法 | |
HUP0000808A3 (en) | Pharmaceutical composition of fenofibrate and method for preparing same | |
HUP0300836A3 (en) | Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same | |
PL344246A1 (en) | Novel pharmaceutical composition for use in emergency treatment and preparation method thereof | |
AUPO727097A0 (en) | Method of treatment of hepatoma and pharmaceutical compositions for use therein | |
ZA984268B (en) | Method and composition for administering taxanes orally to human patients | |
EP1129217A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING DISEASES | |
PL341230A1 (en) | Solid dosage forms of ribavirin for oral administration and method of obtaining them | |
IL122405A (en) | Methods for preparation of pharmaceutical composition for treatment of specific diseases using oils enriched in dha | |
IL149360A0 (en) | Method and compositions for administering taxanes orally to human patients | |
EP1181022A4 (en) | MEDICAL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF | |
EP1210075A4 (en) | COMPILATIONS AND METHODS FOR CHANGING THE FAT IN THE SKIN | |
HUP9904317A3 (en) | Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases | |
HUP0001526A3 (en) | Use of nucleozides for producing pharmaceutical compositions for cytokine related treatments of disease and the pharmaceutical compositions | |
ZA964517B (en) | Oral pharmaceutical composition of piperidinoalkanol compounds in solution form | |
EP1009433A4 (en) | THERAPEUTIC COMPOSITION AND TREATMENT METHOD | |
AU784159C (en) | Method and compositions for administering taxanes orally to human patients | |
HUP0203676A3 (en) | Pharmaceutical composition and method for treatment of diabetes | |
HUP9801869A3 (en) | Pharmaceutical composition for enhancing level of l-carnitin in human patients | |
GB9608927D0 (en) | Method of treatment and pharmaceutical composition |